Skip to main content

Table 5 Adverse events associated with MDR-TB treatment during the intensive phase (N = 19)

From: Evaluation of risk factors associated with drug-resistant tuberculosis in Yemen: data from centres with high drug resistance

Adverse events

Patientsa, N (%)

Gastrointestinal effects

4 (13.3)

Arthralgia

2 (6.7)

Psychiatric disorders

1 (3.3)

Hearing disturbance

2 (6.7)

Renal toxicity

1 (3.3)

Peripheral neuropathy

1 (3.3)

Hepatic toxicity

2 (6.7)

Dermatological reactions

1 (3.3)

Haematological reactions

2 (6.7)

Others

3 (10)

  1. aDrug-resistant patients with more than one adverse reaction